Pharma assns demand setting up of NIPER in silk city

Berhampur:  Several pharmacist associations staged a rally on Monday and submitted a memorandum to Prime Minister Narendra Modi and chief minister Mohan Charan Majhi through the revenue divisional commissioner (south) demanding establishment of a National Institute of Pharmaceutical Education and Research (NIPER) in Berhampur.

Members of the South Odisha Pharmacists Association (SOPA), Ganjam-Phulbani Druggists’ and Chemists Association (GPDCA), and several pharmacy students from different institutes here took part in the rally. The rally started from MKCG Medical College and Hospital and went until the RDC’s residence.

P Satyanarayana, president of GPDCA, said pharmacy education started in the state in 1979. “There are five pharmacy institutes in the city that are imparting BPharm and MPharm courses. Students who pass out are doing jobs in various companies. If NIPER is established in Berhampur, students from Odisha and neighbouring states would benefit,” he said.

Bijay Kumar Swain, president of SOPA, said Berhampur has all the potential facilities for the establishment of NIPER. “Its establishment is important as the state govt has planned to set up a pharma cluster in Gopalpur by inviting pharmaceutical companies. Several pharma companies have also shown their keenness to set up units in Gopalpur,” he said.

Earlier, several social activists and all BJP MLAs of Ganjam district submitted memorandums to Majhi demanding the establishment of NIPER at Berhampur, while local MP Pradeep Kumar Panigrahy wrote a letter to the PM and CM in this regard.

NIPERs are now functioning at Mohali, Ahmedabad, Hajipur, Hyderabad, Kolkata, Guwahati and Rae Bareli.

Related Posts

AbbVie loses patent plea for Hep C drug

New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…

GSK’s Calpol a well-known trademark: High Court

New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer